NASDAQ:SDGR Schrödinger (SDGR) Stock Forecast, Price & News $27.38 +0.04 (+0.15%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$27.13▼$27.9950-Day Range$27.34▼$53.7952-Week Range$15.85▼$59.24Volume884,714 shsAverage Volume956,067 shsMarket Capitalization$1.97 billionP/E Ratio31.84Dividend YieldN/APrice Target$52.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Schrödinger MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside89.9% Upside$52.00 Price TargetShort InterestBearish11.29% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.97Based on 3 Articles This WeekInsider TradingSelling Shares$1 M Sold Last QuarterProj. Earnings GrowthDecreasingFrom $0.61 to ($1.51) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.25 out of 5 starsMedical Sector378th out of 969 stocksPharmaceutical Preparations Industry159th out of 455 stocks 3.3 Analyst's Opinion Consensus RatingSchrödinger has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $52.00, Schrödinger has a forecasted upside of 89.9% from its current price of $27.38.Amount of Analyst CoverageSchrödinger has only been the subject of 2 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted11.29% of the float of Schrödinger has been sold short.Short Interest Ratio / Days to CoverSchrödinger has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Schrödinger has recently decreased by 2.12%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSchrödinger does not currently pay a dividend.Dividend GrowthSchrödinger does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SDGR. Previous Next 3.3 News and Social Media Coverage News SentimentSchrödinger has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Schrödinger this week, compared to 2 articles on an average week.Search InterestOnly 8 people have searched for SDGR on MarketBeat in the last 30 days. This is a decrease of -76% compared to the previous 30 days.MarketBeat Follows19 people have added Schrödinger to their MarketBeat watchlist in the last 30 days. This is an increase of 111% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Schrödinger insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,002,600.00 in company stock.Percentage Held by InsidersOnly 7.60% of the stock of Schrödinger is held by insiders.Percentage Held by Institutions81.14% of the stock of Schrödinger is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Schrödinger are expected to decrease in the coming year, from $0.61 to ($1.51) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Schrödinger is 31.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 124.64.Price to Earnings Ratio vs. SectorThe P/E ratio of Schrödinger is 31.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 153.25.Price to Book Value per Share RatioSchrödinger has a P/B Ratio of 4.35. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Schrödinger (NASDAQ:SDGR) StockSchrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.Read More SDGR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SDGR Stock News HeadlinesSeptember 28, 2023 | stockhouse.comSchrödinger and Two City University of New York Colleges Awarded $1M NSF Grant to Increase Access to Computational Molecular Modeling EducationSeptember 19, 2023 | americanbankingnews.comSchrödinger, Inc. (NASDAQ:SDGR) Given Average Rating of "Moderate Buy" by AnalystsSeptember 29, 2023 | Behind the Markets (Ad)Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer'sA small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>September 16, 2023 | finance.yahoo.comSDGR Sep 2023 45.000 callSeptember 5, 2023 | finance.yahoo.comSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceSeptember 2, 2023 | seekingalpha.comSchrodinger: More Than An AI Bubble StockAugust 16, 2023 | seekingalpha.comSchrodinger: A Computational Platform That Is Likely Becoming ObsoleteAugust 5, 2023 | msn.comMorgan Stanley Reiterates Schrodinger (SDGR) Equal-Weight RecommendationSeptember 29, 2023 | Behind the Markets (Ad)Jeff Bezos Backs "Drug Smuggler" to Fight Alzheimer'sA small, publicly traded biotech is racing to the discovery of a lifetime: Using a Drug Smuggler to Fight Alzheimer's, Parkinson's and Dementia. This radical treatment is so promising, Biogen, Sanofi and Genentech paid $1 billion to license it. Click here to learn more >>>August 3, 2023 | marketwatch.comSchrödinger Shares Tumble 22% on 2Q Revenue Decline, Lower 2023 OutlookAugust 3, 2023 | finance.yahoo.comWhy Shares of Schrödinger Are Falling ThursdayAugust 3, 2023 | benzinga.comWhy Is Schrödinger Stock Tumbling Today?August 3, 2023 | technews.tmcnet.comSchrödinger Reports Second Quarter 2023 Financial ResultsAugust 2, 2023 | seekingalpha.comSchrödinger, Inc. 2023 Q2 - Results - Earnings Call PresentationAugust 2, 2023 | msn.comSchrodinger (SDGR) Price Target Increased by 5.40% to 59.73July 26, 2023 | seekingalpha.comCracking The Code: Schrödinger's AI Dance In Drug DiscoveryJuly 19, 2023 | finance.yahoo.comSchrödinger to Announce Second Quarter 2023 Financial Results on August 2July 6, 2023 | msn.comSchrodinger (SDGR) Price Target Increased by 7.30% to 56.67July 6, 2023 | seekingalpha.comSchrodinger: Getting Ready To Buy An AI WinnerJune 29, 2023 | msn.comMorgan Stanley Maintains Schrodinger (SDGR) Equal-Weight RecommendationJune 16, 2023 | finance.yahoo.comWhy Shares of Schrödinger Rose This WeekJune 14, 2023 | finance.yahoo.comSchrodinger, Inc. (SDGR) Surges 6.6%: Is This an Indication of Further Gains?May 26, 2023 | finance.yahoo.comSchrödinger to Present at Jefferies Global Biopharma ConferenceMay 22, 2023 | uk.finance.yahoo.comSchrödinger, Inc. (SDGR) stock historical prices & data – Yahoo FinanceMay 21, 2023 | seekingalpha.comSchrodinger: Reiterate Buy Rating On Strong Software Revenue Growth AheadMay 8, 2023 | msn.comCitigroup Maintains Schrodinger (SDGR) Buy RecommendationMay 5, 2023 | markets.businessinsider.comSchrodinger (SDGR) Gets a Hold from Bank of America SecuritiesSee More Headlines Receive SDGR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Schrödinger and its competitors with MarketBeat's FREE daily newsletter. Email Address SDGR Company Calendar Last Earnings8/02/2023Today9/29/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SDGR CUSIPN/A CIK1490978 Webwww.schrodinger.com Phone212-295-5800FaxN/AEmployees787Year FoundedN/APrice Target and Rating Average Stock Price Forecast$52.00 High Stock Price Forecast$67.00 Low Stock Price Forecast$23.00 Forecasted Upside/Downside+89.9%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.86 Trailing P/E Ratio31.84 Forward P/E Ratio44.89 P/E GrowthN/ANet Income$-149,190,000.00 Net Margins34.24% Pretax Margin37.33% Return on Equity-20.98% Return on Assets-14.62% Debt Debt-to-Equity RatioN/A Current Ratio5.54 Quick Ratio5.54 Sales & Book Value Annual Sales$180.96 million Price / Sales10.88 Cash FlowN/A Price / Cash FlowN/A Book Value$6.29 per share Price / Book4.35Miscellaneous Outstanding Shares71,880,000Free Float66,417,000Market Cap$1.97 billion OptionableNot Optionable Beta1.29 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Ramy Farid Ph.D. (Age 58)CEO, Pres & Director Comp: $1.04MDr. Richard A. Friesner Ph.D. (Age 70)Co-Founder, Scientific Advisory Chairman and Director Comp: $455kDr. Geoffrey Craig Porges MBBSExec. VP & CFODr. Robert Lorne Abel Ph.D. (Age 41)Exec. VP of Science, Chief Computational Scientist and Head of Modeling R&D Comp: $528.37kMs. Yvonne Tran Esq. (Age 52)Chief Legal & People Officer Comp: $670.1kDr. Karen Akinsanya Ph.D. (Age 55)Pres of R&D Therapeutics Comp: $777.68kMs. Jenny HermanSr. VP of Fin. & Corp. ControllerProf. William Goddard IIICo-Founder & Scientific AdvisorMr. Kenneth Patrick Lorton (Age 39)Exec. VP & CTO Mr. Shane Brauner (Age 45)Exec. VP & Chief Information Officer More ExecutivesKey CompetitorsVentyx BiosciencesNASDAQ:VTYXHarmony BiosciencesNASDAQ:HRMYGemini TherapeuticsNASDAQ:GMTXDynavax TechnologiesNASDAQ:DVAXPTC TherapeuticsNASDAQ:PTCTView All CompetitorsInsiders & InstitutionsCGC Financial Services LLCBought 4,221 shares on 9/13/2023Ownership: 0.006%Wolverine Trading LLCBought 1,600 shares on 8/23/2023Ownership: 0.000%California State Teachers Retirement SystemSold 1,658 shares on 8/21/2023Ownership: 0.098%Teachers Retirement System of The State of KentuckyBought 17,800 shares on 8/21/2023Ownership: 0.025%Legato Capital Management LLCBought 5,170 shares on 8/18/2023Ownership: 0.007%View All Insider TransactionsView All Institutional Transactions SDGR Stock - Frequently Asked Questions Should I buy or sell Schrödinger stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Schrödinger in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" SDGR shares. View SDGR analyst ratings or view top-rated stocks. What is Schrödinger's stock price forecast for 2023? 5 brokerages have issued 12 month target prices for Schrödinger's shares. Their SDGR share price forecasts range from $23.00 to $67.00. On average, they expect the company's share price to reach $52.00 in the next year. This suggests a possible upside of 89.9% from the stock's current price. View analysts price targets for SDGR or view top-rated stocks among Wall Street analysts. How have SDGR shares performed in 2023? Schrödinger's stock was trading at $18.69 at the beginning of 2023. Since then, SDGR stock has increased by 46.5% and is now trading at $27.38. View the best growth stocks for 2023 here. When is Schrödinger's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our SDGR earnings forecast. How were Schrödinger's earnings last quarter? Schrödinger, Inc. (NASDAQ:SDGR) announced its quarterly earnings results on Wednesday, August, 2nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.43) by $0.22. The firm earned $35.19 million during the quarter, compared to analyst estimates of $35.28 million. Schrödinger had a negative trailing twelve-month return on equity of 20.98% and a net margin of 34.24%. What ETFs hold Schrödinger's stock? ETFs with the largest weight of Schrödinger (NASDAQ:SDGR) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), TrueShares Technology, AI & Deep Learning ETF (LRNZ), Tuttle Long Cramer Tracker ETF (LJIM), Subversive Mental Health ETF (SANE), Jacob Forward ETF (JFWD), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR FactSet Innovative Technology ETF (XITK) and Motley Fool Small-Cap Growth ETF (TMFS). What guidance has Schrödinger issued on next quarter's earnings? Schrödinger issued an update on its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $205.91 million-$229.98 million, compared to the consensus revenue estimate of $208.42 million. What is Ramy Farid's approval rating as Schrödinger's CEO? 8 employees have rated Schrödinger Chief Executive Officer Ramy Farid on Glassdoor.com. Ramy Farid has an approval rating of 95% among the company's employees. This puts Ramy Farid in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Schrödinger own? Based on aggregate information from My MarketBeat watchlists, some companies that other Schrödinger investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Tesla (TSLA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Block (SQ), Cisco Systems (CSCO), Teladoc Health (TDOC), Alteryx (AYX) and QUALCOMM (QCOM). When did Schrödinger IPO? (SDGR) raised $150 million in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, BofA Securities, Jefferies and BMO Capital Markets served as the underwriters for the IPO. What is Schrödinger's stock symbol? Schrödinger trades on the NASDAQ under the ticker symbol "SDGR." How do I buy shares of Schrödinger? Shares of SDGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Schrödinger's stock price today? One share of SDGR stock can currently be purchased for approximately $27.38. How much money does Schrödinger make? Schrödinger (NASDAQ:SDGR) has a market capitalization of $1.97 billion and generates $180.96 million in revenue each year. The company earns $-149,190,000.00 in net income (profit) each year or $0.86 on an earnings per share basis. How many employees does Schrödinger have? The company employs 787 workers across the globe. How can I contact Schrödinger? Schrödinger's mailing address is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. The official website for the company is www.schrodinger.com. The company can be reached via phone at 212-295-5800 or via email at christina.tartaglia@sternir.com. This page (NASDAQ:SDGR) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Schrödinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.